
PitchBook and the NVCA published their Q3 Venture Monitor in October, and the headline number is a record: U.S. venture-backed exit value reached $2.29 trillion across an estimated 1,240 exits through the third quarter of 2026. But SpaceX’s $1.7 trillion listing in the second quarter — the largest IPO ever — is nearly three-quarters of that total on its own. In the third quarter, SpaceX’s $60 billion purchase of Cursor was 53.1% of the quarter’s entire exit value. The rest of the quarter totaled $53 billion, the lowest since the end of 2024. Acquisition value is at a decade high of $465.3 billion, and M&A ‘has become the preferred, or at least primary, route for liquidity.’
Two rounds announced yesterday show what buyers actually buy. Axle raised a $9 million round led by Eniac and Bonfire Ventures to run corporate access for investment banks — more than a dozen sell-side firms already use it, including three of North America’s largest banks. Mondrio raised a $3.75 million seed led by Heartcore Capital for AI agents that set prices and guide discounts — founded by pricing veterans with thirty years behind them. In both cases, the proof is an audience that already listens.
The lesson is one I wrote about in The Impact Factor, in a chapter called “Finding Your Audience”: “It doesn’t matter who you are, what your opinions might be or even whether you have anything to say worth listening to. Someone is willing to listen to YOU right now.” And: “The best way to spread your message is to start by observing what is already being shared, discussed and admired by your audience.” An acquirer does the same thing. Your audience is your exit. Build the room, and the buyer already knows where to find you.
Founders: start with a 21-day free trial of Founder Pro at connectlab.live/founders. Funds: connectlab.live/join/funds.
Sources: PitchBook–NVCA Venture Monitor, Q3 2026 (data as of September 30, 2026); GlobeNewswire company release for Mondrio (Nov 12, 2026); company announcement for Axle (Nov 12, 2026). Not legal or investment advice.
